Skip to content
WeighLab
Grade C

Maximus Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Maximus sells compounded tirzepatide at one flat rate for every dose, from $249.99 a month on its shortest two-month plan down to $149.99 on a 12-month plan, each billed up front.

Visit Maximus Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not offered
Tirzepatide
$249.99/mo2-month plan, billed up front, compounded
Coverage
47 states
Brand-name
Yes

Tirzepatide · modeled / year

$2,988

The Index scorecard

Maximus scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month51/100
Price Transparency94/100
Nationwide Access78/100
Formulation Options95/100
Clinical Oversight78/100
Contract Flexibility37/100

Where the value is

  • Its pricing FAQ lists every plan length: $249.99 a month on 2 months, $219.99 on 4, $199.99 on 6 and $149.99 on 12, with no separate first-month price
  • One flat rate covers every dose tier, with no membership fee and free shipping
  • Also offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro pens plus the Wegovy and Foundayo tablets
  • Board-certified doctors review your history, and you can message your doctor any time without an appointment
  • Available in every state except Alabama, Louisiana and Mississippi, and HSA and FSA cards are accepted

The tradeoffs

  • There is no month-to-month tirzepatide plan: the shortest is two months, billed up front, and plans renew automatically at the same term
  • No compounded semaglutide option
  • No refund on medication once it has shipped, and if you aren't approved you are refunded minus the cost of the doctor consultation
  • Brand-name pricing is unclear: one page says plans start at $199.99, another says from $499 a month, and the product pages show no price
  • The compounding pharmacy isn't named, only described as a licensed U.S. pharmacy
  • Compounded tirzepatide is not an FDA-approved product
  • FDA issued Maximus Health, Inc. dba Maximus a warning letter in June 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account. Maximus sells compounded tirzepatide at one flat rate for every dose, from $249.99 a month on its shortest two-month plan down to $149.99 on a 12-month plan, each billed up front.

For comparison, read our review of CoreAge Rx, one of our partners. Partners are listed first on our leaderboard; every provider is scored on the same six factors.

Other programs to compare with Maximus

These are partners: we may earn a commission if you sign up, at no cost to you.

  • RNK HealthPartner

    Semaglutide from $197/mo · tirzepatide from $297/mo

    Compounded semaglutide from $197 a month and tirzepatide from $297, with the doctor visit, medication, supplies and shipping in one monthly price you can cancel.

  • CoreAge RxPartner

    Semaglutide from $99/mo · tirzepatide from $149/mo

    CoreAge Rx charges one flat price at every dose, $99 a month for semaglutide and $149 for tirzepatide, with no membership fee.

  • EdenPartner

    Semaglutide from $99/mo · tirzepatide from $129/mo

    Eden charges $99 a month for compounded semaglutide and $129 for compounded tirzepatide, the same at every dose, with the visit, medication and shipping included.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Maximus's. See the alternatives to Maximus.

The 20 programs nearest this one

Pricing, states and verification reflect Maximus's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Maximus's site. Not medical advice; see our disclosure.

← Back to the value leaderboard